Intuitive Surgical, Inc. $ISRG Stock: Annex Advisory Services LLC Lowers Position

Key Points

• Annex Advisory Services LLC cut its Intuitive Surgical stake by 37.8% in the third quarter, selling 34,396 shares and retaining 56,547 shares valued at approximately $22.99 million. Institutional investors collectively own 83.64% of the company.
• Analyst sentiment remains favorable, with a consensus rating of “Moderate Buy” and an average price target of $498.83, although several firms recently lowered their targets.
• Intuitive Surgical reported strong operating results, including 18.4% year-over-year revenue growth and quarterly EPS of $2.80 versus the $2.48 consensus estimate. Investors remain focused on procedure growth and demand amid slowing U.S. growth, China-related headwinds and the stock’s premium valuation.

Annex Advisory Services LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 37.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,547 shares of the medical equipment provider's stock after selling 34,396 shares during the quarter. Annex Advisory Services LLC's holdings in Intuitive Surgical were worth $22,994,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. 3Chopt Investment Partners LLC lifted its position in shares of Intuitive Surgical by 5.2% in the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider's stock worth $213,000 after buying an additional 23 shares in the last quarter. Vermillion Wealth Management Inc. boosted its position in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider's stock valued at $31,000 after acquiring an additional 25 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co grew its holdings in shares of Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider's stock valued at $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. grew its holdings in shares of Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider's stock valued at $2,210,000 after purchasing an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC increased its position in Intuitive Surgical by 4.1% in the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider's stock worth $255,000 after purchasing an additional 25 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the sale, the executive vice president owned 881 shares of the company's stock, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares of the company's stock, valued at $2,016,280. This represents a 6.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Raymond James Financial reaffirmed an "outperform" rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Mizuho set a $415.00 price objective on shares of Intuitive Surgical in a research note on Tuesday. Piper Sandler reissued an "overweight" rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Weiss Ratings restated a "hold (c)" rating on shares of Intuitive Surgical in a report on Friday, August 14th. Finally, Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $498.83.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Intuitive Surgical Stock Down 0.3%

ISRG stock opened at $426.70 on Friday. The business's fifty day simple moving average is $391.43 and its two-hundred day simple moving average is $409.74. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The firm has a market cap of $150.74 billion, a price-to-earnings ratio of 51.24, a PEG ratio of 3.23 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the company earned $1.81 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.